US 7378108
Percutaneous absorption preparation of compound having angiotensin II antagonistic activity
granted A61KA61K31/4178A61K31/4245
Quick answer
US patent 7378108 (Percutaneous absorption preparation of compound having angiotensin II antagonistic activity) held by Takeda Pharmaceutical Company Limited expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/4178, A61K31/4245, A61K47/10, A61K47/14